FIDE BIOTECHNOLOGY SL
Company details
- No Activa NIF/CIF: B87424131
-
Telephone: Not available
-
Date of last BORME entry: 05/09/2017
-
Sector: Actividades profesionales, científicas y técnicas
-
Address: Calle Acebuche, 18, 28023 Madrid, Madrid, España See in map
-
Website: Not available
-
Featured products:
More information on FIDE BIOTECHNOLOGY SL
-
05/09/2017 | BORME act no.: 359744 | Register: MADRIDCeses/Dimisiones -
05/09/2017 | BORME act no.: 359744 | Register: MADRIDNombramientos
-
05/09/2017 | BORME act no.: 359744 | Register: MADRIDDisolución
-
15/12/2015 | BORME act no.: 507214 | Register: MADRIDConstitución
-
15/12/2015 | BORME act no.: 507214 | Register: MADRIDNombramientos
Other information
The CIF assigned to FIDE BIOTECHNOLOGY SL is B87424131, and its commercial status is dissolved. The company is engaged in economic activities classified under the CNAE 7219 - Otra investigación y desarrollo experimental en ciencias naturales y técnicas. Additionally, it is categorized with the SIC code 8731 - Investigación física comercial.
FIDE BIOTECHNOLOGY SL employs approximately Between 1 and 9 employees and records an annual turnover of less than 2 million euros. The company is registered in the Commercial Registry of Madrid, and has 2 registration charges. The most recent announcement in Borme was published on 05/09/2017, while the last deposit of ordinary annual accounts corresponds to the year -.
To find out the contact information of FIDE BIOTECHNOLOGY SL, such as the telephone number, postal address, or website, you can access the Company Data module.
If you wish to obtain additional information about FIDE BIOTECHNOLOGY SL, we invite you to consult any of the available financial reports, the Annual Accounts of the company, or review the incidents of defaults registered in the RAI delinquency file.
The financial, commercial, and legal information about FIDE BIOTECHNOLOGY SL comes from official data sources and is automatically updated every day.
Do you want to know more about FIDE BIOTECHNOLOGY SL??
Find out more about this company by consulting these reports:
